Weight Management in Obese Cancer Patients During Curative Active Treatment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitut d'Investigació Biomèdica de Bellvitge
About this trial
This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain.
The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.
Eligibility criteria
Qualifiers
Adult (age 18+) with pathologically confirmed malignant solid tumors, stage II-IV, elected for oncological treatment (chemo, radio, or both) with curative intend.
Expected oncological treatment time ≥ 3 months.
BMI ≥ 30 kg/m²
Resident in the Barcelona area up to the completion of cancer treatment.
Disqualifiers
Patients with melanoma and brain tumours.
Surgery as the only treatment.
Pregnancy or breastfeeding
Another active malignancy
Trial design
Treatments tested in this trial
- Multimodal weight management program
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Institut d'Investigació Biomèdica de Bellvitge
Lead sponsor
World Cancer Research Fund International
Collaborator
Institut Català d'Oncologia
Collaborator
Source ClinicalTrials.gov